Observational Study
researchers track health outcomes over time in groups of participants to look for patterns that help us better understand a disease.
Protein in Urine
A Multicenter, Observational, Cross-sectional Study to estimate the Frequencies of APOL1 Genetic Variants, and explore kidney disease Biomarkers in Adult Black and African-American Patients with Proteinuric Kidney Disease.
Brief Description
Observational study that is one visit that after the Informed consent is signed, medical history is reviewed, and blood and urine specimens are collected. Optional genetic counseling is offered as well.
Site Name
AB Clinical Trials
2110 East Flamingo Road suite 103 Las Vegas, NV 89119
Sponsor
Maze Therapeutics
Study Drug
MZE829
Estimated enrollment
60
Estimated end date
May 2025
Observational Study
researchers track health outcomes over time in groups of participants to look for patterns that help us better understand a disease.
Protein in Urine
A Multicenter, Observational, Cross-sectional Study to estimate the Frequencies of APOL1 Genetic Variants, and explore kidney disease Biomarkers in Adult Black and African-American Patients with Proteinuric Kidney Disease.
Brief Description
Observational study that is one visit that after the Informed consent is signed, medical history is reviewed, and blood and urine specimens are collected. Optional genetic counseling is offered as well.
Trial is for people with
18-65 year olds with moderate Proteinuria
Study Goal
To catch more patients of Black, African-American, Afro-Latino decent with kidney disease due to APOL1 Gene.
What is involved for the Patient?
Reading and signing of informed consent, review of medical history and medications, and collection of blood and urine samples.
About the drug or intervention
No intervention for this trial, but this is a trial if the patient tests APOL1 positive that they may be referred to